Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion description "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion evidence source_evidence_literature NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion SIO_000772 22988110 NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion wasDerivedFrom befree-20150227 NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion wasGeneratedBy ECO_0000203 NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.